Adults stop anti-rejection drugs after stem-cell transplant reverses sickle cell disease
– Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease, according to a study in the July 1 issue of the Journal of the American Medical Association. The trial was conducted at the National Institutes of Health’s Clinical Center in Bethesda, Maryland, by researchers from NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute.
* July 1 2014 issue of the Journal of the American Medical Association
– http://healthresearchreport.me/2014/07/03/adults-stop-anti-rejection-drugs-after-stem-cell-transplant-reverses-sickle-cell-disease/
Related articles
- Adults Stop Anti-rejection Drugs Following Stem-cell Transplant may Reverse Sickle Cell Disease (medindia.net)
- New Sickle Cell Disease Treatment Eliminates Need Of Immunosuppressants After Stem Cell Transplant (medicaldaily.com)
- Adults Stop Anti-rejection Drugs After Partial Stem-cell Transplant Reverses Sickle Cell Disease (hispanicbusiness.com)
- Adults stop anti-rejection drugs after stem-cell transplant reverses sickle cell disease (eurekalert.org)
- Adults stop anti-rejection drugs after partial stem-cell transplant reverses sickle cell disease (foodconsumer.org)